期刊文献+

萝卜硫素可通过拮抗PXR受体抑制钠磷转运蛋白NaPi-IIb表达

Sulforaphane Reduces the Expression of the Na Pi-IIb Through Pregnane X Receptor
下载PDF
导出
摘要 目的:SLC34a2基因编码的钠依赖性磷转运蛋白Na Pi-IIb在磷的吸收中起重要作用,减少CKD患者磷的肠道吸收可能是治疗其高磷血症的潜在方案。本研究旨在探索萝卜硫素(sulforaphane,SFN)能否通过拮抗孕烷X受体(pregnane X receptor,PXR)抑制人源性结肠癌细胞中Na Pi-IIb表达,为高磷血症寻找新治疗靶点。方法:RT-qPCR检测3种结肠癌细胞系HT29、LOVO及SW480中PXR及SLC34a2 mRNA表达量;MTT法确定SFN及利福平(Rifampicin,RFP)的适宜作用浓度和时间;RT-qPCR和Westernblot分别检测药物处理后细胞系SLC34a2 mRNA和NaPi-IIb的表达情况;观察探讨SFN、PXR及Na Pi-IIb三者之间的关系。结果:(1)10μmol/L和20μmol/L SFN均可抑制LOVO细胞中SLC34a2 mRNA及NaPi-IIb表达,且后者的抑制效果更强。(2)10μmol/L SFN可降低由10μmol/L RFP诱导的SLC34a2 mRNA和Na Pi-IIb高表达。结论:SFN对SLC34a2 mRNA及NaPi-IIb表达存在确切抑制作用;SFN可竞争性抑制RFP激活PXR引起的Na Pi-IIb升高,表明SFN对NaPi-IIb的抑制作用可通过SFN-/-PXR-NaPi-IIb通路实现。 Objective : NaPi - IIb sodium - dependent phosphate transporter protein, which is encoded by SLC34a2 gene, plays a dominant role in intestinal phosphorus absorption. The reduction of intestinal phosphorus absorption is a potential treatment tot hyperphosphatemia in CKD patients. This paper aimed to investigate whether sulforaphane (SFN) could reduce the expression of NaPi - lib through antagonizing pregnane X receptor (PXR). Methods: RT - qPCR was conducted to examine the expression levels of PXR and SLC34a2 in three colon cancer cell lines, HT29 ,LOVO and SW480. MTT assay was conducted to determine the proper dose and time for SFN and Rifampicin(RFP) treatment. Then, RT - qPCR and westernblot were conducted to examine the expression level of SLC34a2 mRNA and NaPi - lib, respectively. Furthermore, the relationship among SFN, PXR and NaPi - Ilb was revealed. Re- sults:( 1 ) SFN with concentration levels of 10 p, mol/L and 20 μmol/L significantly reduced the expression of SLC34a2 mRNA anti NaPi- lib in LOVO cells. Moreover, SFN with higher concentration level showed stronger suppresion effects. (2) 10 μmol/L SFN attenuated the increase of SLC34a2 mRNA and NaPi - lib induced by 10 μmol/L RFP. Conclusion: SFN carl reduce the expression of NaPi - IIb and this effect is realized by a potential signal pathway SFN - / - PXR - NaPi -IIb.
出处 《中国中西医结合肾病杂志》 2016年第7期578-581,共4页 Chinese Journal of Integrated Traditional and Western Nephrology
基金 陕西省社会发展科技攻关项目(No.2013K12-040-01)
关键词 高磷血症 萝卜硫素 SLC34a2 孕烷X受体 Hyperphosphatemia Sulforaphane SLC34a2 Pregnane X receptor
  • 相关文献

参考文献14

  • 1Melamed ML. Changes in serum caMum, phosphate, and PTH and the risk of death in incident dialysis patients:a longitudinal study. Kidney Int, 2006,70 ( 2 ) : 351 - 357.
  • 2石敏,周莉,付平.慢性肾脏病高磷血症肾损伤机制的研究进展[J].中国中西医结合肾病杂志,2016,17(1):76-78. 被引量:7
  • 3Madsen KL. Stanniocalcin:a novel protein regulating calcium and phosphate transport across mammalian intestine. Am J Physiol, 1998,274( 1 ) :96 - 102.
  • 4Forsler I. Phosphate transporters in renal, gastrointestinal, and other tissues. Adv Chronic Kidney Dis ,2011,18 ( 2 ) :63 - 76.
  • 5Konno Y. Nuclear xenobiotic receptor PXR - null mouse exhibits hypophosphatemia and represses the Na/Pi - cotransporter SLC34A2. Pharmacogenet Genomics ,2010,20( 1 ) :9 - 17.
  • 6Schwab M. The dietaβ, histone deacetylase inhibitor sulforaphane induces human beta- defensin -2 in intestinal epithelial ceils. Immunology,2008,125 ( 2 ) : 241 - 251.
  • 7Kim B. Global metabolomics and targeted steroid profiling reveal that rifampin, a strong human PXR activator, alters endogenous urioa~ steroid markers. J Proleome Res, 2013,12 ( 3 ) : 1359 - 1368.
  • 8Sahbagh Y. Intestinal npt2b plays a major role in phosphate ab- sorption and homeostasis. J Am Soc Nephrol, 2009,20 ( 11 ) : 2348 - 2358.
  • 9Zhou C. The dietary isothiocyanate sullbraphane is an antagonist of the human steroid and xenobiotic nuclear receptor. Mol Phar- macol,2007,71 ( 1 ) :220 -229.
  • 10Mukherjee S, H Gangopadhyay, DK Das. Broccoli: a unique vegetable that protects mammalian hearts thruugh the redox cy- cling of the thioredoxin superfamily. J Agric Food Chem,2008, 56(2) :609 -617.

二级参考文献39

  • 1Molony DA, Stephens BW. Derangements in phosphate metabolism in chronic kidney diseases/endstage renal disease:therapeutic considerations. Adv Chronic Kidnly Dis, 2011,18 ( 2 ) : 120 - 131.
  • 2Ketteler M, Biggar PH. Use of phosphate binders in chronic kidney disease. Curr Opin Nephrol Hypertens ,2013,22(4) :413 -420.
  • 3Klonoff DC. Fibroblast growth factor: will this hormone be the hemoglobin A1 c for managing phosphorus balance in chronic kidney disease. J Diabetes Sci Technol,2010,4(4) :770-772.
  • 4Zoccali C, Ruggenenti P, Perna A, et al. Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. J Am Soc Nephrol, 2011,22 (10) : 1923 - 1930.
  • 5Lee H, Oh SW, Heo N J, et al. Serum phosphorus as a predictor of low- grade albuminuria in a general population without evidence of chronic kidney disease. Nephrol Dial Transplant, 2012, 27 (7) :2799 - 2806.
  • 6Takeda E, Taketani Y, Nashiki K, et al. A novel function of phosphate - mediated intracellular signal transduction pathways. Adv Enzyme Regul,2006,46( 1 ) :154 - 161.
  • 7Shuto E, Taketani Y, Tanaka R, et al. Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol, 2009,20 ( 7 ) : 1504 - 1512.
  • 8Six I, Maizel J, Barreto FC, et al. Effects of phosphate on vascular function under normal conditions and influence of the uraemic state. Cardiovasc Res,2012,96 ( 1 ) : 130 - 139.
  • 9Di Marco GS, Hausberg M, Hillebrand U, et al. Increased inorganic phosphate induces human endothelial cell apoptosis in vitro. Am J Physiol Renal Physiol,2008,294 (6) : F1381 - F1387.
  • 10Chironi GN, Boulanger CM, Simon A, et al. Endothelial mieroparticles in diseases. Cell Tissue Res,2009,335 ( 1 ) : 143 - 151.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部